20Slash20 Inc., the company behind The Eye Drink, is set to showcase its innovative functional beverage at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for September 9–10, 2026, in New York City. CEO Dr. Roger Wu will deliver an investor presentation at 9:35 a.m. ET on September 9 at The Westin New York Grand Central, followed by one-on-one meetings with investors. This participation marks a significant milestone for the company as it seeks to attract investment and expand its footprint in the rapidly growing functional beverage market.
The Eye Drink is positioned as the world’s first ready-to-drink functional beverage specifically formulated with science-backed ingredients to support eye health for individuals who spend prolonged periods on digital devices. With the average person spending over seven hours daily on screens, the product addresses a pervasive and escalating health concern. The beverage offers a convenient and palatable solution, aiming to protect eyes from screen-induced strain and related issues, which have become increasingly common in today’s screen-centric world.
The conference, organized by Moody Capital Solutions, brings together growth companies, investors, and industry professionals across life sciences and other emerging sectors. For 20Slash20, this platform provides an opportunity to engage with potential investors and strategic partners, highlighting the commercial viability and societal relevance of its product. The company’s participation underscores the growing investor interest in health-oriented consumer products that leverage scientific research to meet modern lifestyle demands.
The implications of this presentation extend beyond immediate fundraising. It signals a broader trend where consumer health products are increasingly scrutinized for scientific credibility. 20Slash20’s emphasis on “science-backed ingredients” could set a precedent for other functional beverage companies, raising the bar for efficacy and transparency in the industry. Moreover, by targeting eye health—a concern that resonates with a vast demographic, including remote workers, students, and gamers—the company taps into a substantial market segment that is likely to expand as digital device usage continues to rise.
Investors attending the conference will have the chance to evaluate 20Slash20’s business model, market strategy, and growth prospects firsthand. The company’s innovative approach to addressing a common health issue through a daily consumable product could position it as a leader in the niche of eye-health-focused nutrition. As the conference convenes in New York, a hub of financial and medical innovation, 20Slash20’s presentation is expected to generate considerable interest among attendees seeking disruptive growth opportunities.
For more information about the conference and 20Slash20’s participation, interested parties are encouraged to review the full press release at https://ibn.fm/tm2lT. Additional details about the company and its products can be found through official channels. This event represents a pivotal moment for 20Slash20 as it seeks to solidify its position in the functional beverage market and bring its vision of eye health to a wider audience.
